Alex started his successful investment career in the early 1990’s and was quickly named one of the top ranking biotech analysts by both Institutional Investors Magazine and the Greenwich Survey. Alex went on to lead both Biotech and Life Sciences research for three major brokerage houses, including Donaldson, Lufkin & Jenrette, Deutsche Bank, and Credit Suisse First Boston. Alex then joined Duquesne Capital Management as Head of Healthcare Investments, before founding Junction Capital, LLC in the early 2000’s and finally Cross Current Research in 2009. Alex received his M.D. from Boston University and an MBA from the Wharton School of the University of Pennsylvania.
Tom has a long and distinguished investment career spanning over 45 years. He has worked with increasing responsibilities at prestigious firms, including E.M. Warburg, Pincus & Co, Morgan Guarany, Citicorp and Mutual of America. Tom has experience in a variety of industries, including chemicals and agribusiness, aerospace and defense, energy, industrials and consumer staples. As a portfolio manager, Tom deployed a range of investment approaches, including growth and value. He also managed small cap, emerging markets and convertible funds prior to becoming head of equities for Mutual of America.
Dan has over a decade of sell-side experience and worked on derivatives trading desks in both New York and San Francisco prior to joining the Cross Current Research team. Dan is the lead sales contact for our US client base.
Julia has worked in a sales capacity in a variety of industries for over 25 years since joining the Cross Current team. Julia is the lead sales contact for our EU client base.